Development of indazole Rho-kinase (ROCK 1) inhibitors as potential antihypertensive agents

被引：0

作者：

Goodman, Krista Beaver ^{[1
]}

Dowdell, Sarah E. ^{[1
]}

Gaitanopoulos, Dimitri E. ^{[1
]}

Ivy, Robert ^{[1
]}

Sehon, Clark ^{[1
]}

Stavenger, Robert ^{[1
]}

Wang, Gren ^{[1
]}

Viet, Andrew Q. ^{[1
]}

Xu, Weiwei ^{[1
]}

Ye, Guosen ^{[1
]}

Semus, Simon F. ^{[2
]}

Evans, Christopher

Fries, Harvey E. ^{[3
]}

Jolivette, Larry J. ^{[3
]}

Jung, David K. ^{[1
]}

Wright, Lois L. ^{[4
]}

Smith, Gary K. ^{[4
]}

Behm, David J. ^{[5
]}

Bentley, Ross ^{[5
]}

Doe, Christopher P. ^{[5
]}

Hu, Erding ^{[5
]}

Lee, Dennis ^{[1
]}

机构：

[1] GlaxoSmithKline Inc, Dept Med Chem, King Of Prussia, PA 19406 USA

[2] GlaxoSmithKline Inc, Dept Computat & Struct Sci, King Of Prussia, PA 19422 USA

[3] GlaxoSmithKline Inc, Dept Drug Metab & Pharmacokinet, King Of Prussia, PA 19406 USA

[4] GlaxoSmithKline Inc, Screening & Compound Profiling, King Of Prussia, PA 19406 USA

[5] GlaxoSmithKline Inc, Cardiovasc & Urogenital CEDD, Biol, King Of Prussia, PA 19406 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 238卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

252-MEDI

引用

页数：1

共 50 条

[1] Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors
Goodman, Krista B.
Cui, Haifeng
Dowdell, Sarah E.
Gaitanopoulos, Dimitri E.
Ivy, Robert L.
Sehon, Clark A.
Stavenger, Robert A.
Wang, Gren Z.
Viet, Andrew Q.
Xu, Weiwei
Ye, Guosen
Semus, Simon F.
Evans, Christopher
Fries, Harvey E.
Jolivette, Larry J.
Kirkpatrick, Robert B.
Dul, Edward
Khandekar, Sanjay S.
Yi, Tracey
Jung, David K.
Wright, Lois L.
Smith, Gary K.
Behm, David J.
Bentley, Ross
Doe, Christopher P.
Hu, Erding
Lee, Dennis
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (01) : 6 - 9
[2] Therapeutic potential of Rho-kinase inhibitors in asthma
Xing, Xi-Qian
Gan, Ye
Wu, Shang-Jie
Chen, Ping
Zhou, Rui
Xiang, Xu-Dong
MEDICAL HYPOTHESES, 2007, 68 (03) : 705 - 706
[3] Development of Rho-kinase inhibitors for cardiovascular medicine
Shimokawa, Hiroaki
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 37P - 37P
[4] Translational research for the development of Rho-kinase inhibitors
Shimokawa, Hiroaki
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 18P - 18P
[5] Development of Rho-kinase inhibitors for cardiovascular medicine
Shimokawa, Hiroaki
Rashid, Mamunur
TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (06) : 296 - 302
[6] Rho-kinase ROCK inhibitors reduce oligomeric tau protein
Hamano, Tadanori
Shirafuji, Norimichi
Yen, Shu-Hui
Yoshida, Hirotaka
Kanaan, Nicholas M.
Hayashi, Kouji
Ikawa, Masamichi
Yamamura, Osamu
Fujita, Youshi
Kuriyama, Masaru
Nakamoto, Yasunari
NEUROBIOLOGY OF AGING, 2020, 89 : 41 - 54
[7] Therapeutic potential of Rho-kinase inhibitors in cardiovascular diseases
Hirooka Y.
Shimokawa H.
American Journal of Cardiovascular Drugs, 2005, 5 (1) : 31 - 39
[8] Development of specific Rho-kinase inhibitors and their clinical application
Tamura, M
Nakao, H
Yoshizaki, H
Shiratsuchi, M
Shigyo, H
Yamada, H
Ozawa, T
Totsuka, J
Hidaka, H
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1754 (1-2): : 245 - 252
[9] Rho-Kinase/ROCK as a Potential Drug Target for Vitreoretinal Diseases
Yamaguchi, Muneo
Nakao, Shintaro
Arima, Mitsuru
Wada, Iori
Kaizu, Yoshihiro
Hao, Feng
Yoshida, Shigeo
Sonoda, Koh-hei
JOURNAL OF OPHTHALMOLOGY, 2017, 2017
[10] Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
Feng, Yangbo
LoGrasso, Philip V.
Defert, Olivier
Li, Rongshi
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (06) : 2269 - 2300

← 1 2 3 4 5 →